Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
OneMedNet Corporation operates in the healthcare information services sector, focusing on data management solutions for medical records and patient information. Its unique competitive advantage lies in its proprietary data integration platform that enhances interoperability among healthcare providers, primarily in the United States.
OneMedNet generates revenue through subscription fees for its data integration platform, consulting services for healthcare providers, and licensing its software. The company benefits from strong pricing power due to the increasing demand for interoperable healthcare solutions, driven by regulatory requirements and the push for improved patient outcomes.
Adoption rates of electronic health records (EHR) systems by healthcare providers
Regulatory changes mandating data interoperability in healthcare
Partnerships with major healthcare organizations
Technological advancements in data analytics and AI
Technological disruption from emerging healthcare IT solutions
Regulatory changes that could impact data management practices
Increased competition from larger healthcare IT firms
Potential market entry by tech giants with superior resources
Negative gross margins indicating potential pricing pressure
Low current ratio suggesting liquidity concerns
moderate - The company's performance is linked to healthcare spending, which tends to be resilient during economic downturns but can be influenced by broader economic conditions.
Minimal impact from interest rates as the company does not rely heavily on debt financing; however, higher rates could affect overall healthcare spending.
minimal
growth - Investors are likely attracted to the potential for rapid revenue growth in a high-demand sector.
high - The stock has shown significant price volatility, evidenced by a 174.1% return over the past year.
